Harvoni Gains More Differentiation With Updated Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
New indication includes patients with Child-Pugh B and C decompensated cirrhosis, groups that are contraindicated in the labels for Viekira Pak and Zepatier.